Search Results 6861-6870 of 41720 for oral

1. Effect of Spasticity on Motor Neuron Properties - Mayo Clinic

   Active titration of oral baclofen or anti-epileptic medications; History of a selective dorsal rhizotomy; Presence of a baclofen pump; Having any other ...

2. A Study Of VAsotoxicity Surveillance Using EndoPAT: The VASA Pilot Study - Mayo Clinic

   Planned initiation of 5-FU (infusional or bolus-based) or oral capecitabine therapy, either as standard chemotherapy or as a radiosensitizer. ECOG ...

3. A Study of PDD in Type 2 Diabetes - Mayo Clinic

   On at least one oral hypoglycemic agent, or glucagon-like peptide analogue or insulin, for at least 6 months. EF > 50% without diastolic dysfunction or EF ...

4. A Study To Evaluate The Long-Term Safety Of Nintedanib In Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) - Mayo Clinic

   The purpose of this study is to assess the long-term tolerability and safety of oral nintedanib treatment in patients with Progressive Fibrosing ...

5. A Study To Evaluate Hyperthermic Intraperitoneal Chemotherapy To Treat Patients With Pancreatic Cancer And Peritoneal Metastasis - Mayo Clinic

   Adequate contraception consists of oral contraceptive, implantable contraceptives, injectable contraceptives, a double barrier method, or abstinence.

6. Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps - Mayo Clinic

   To evaluate ability of dupilumab in reducing proportion of patients requiring treatment with oral corticosteroids or NP surgery. To evaluate the effect of ...

7. A Study to Evaluate Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients with Dyskeratosis Congenita - Mayo Clinic

   Diagnosis of dyskeratosis congenita based on clinical triad of abnormalities of skin pigmentation, nail dystrophy, oral leukoplakia; OR one of clinical ...

8. A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation - Mayo Clinic

   Four groups including a placebo group will be enrolled and will receive multiple oral doses of YKP10811 or matching placebo. Participation eligibility.

9. Uterine microbe found to have disease-causing behavior in endometrial cancer - Mayo Clinic News Network

   Given the known associations of the microbe's closest relative to oral cancer, the team hypothesized that Porphyromonas somerae could invade and may play a ...

10. Heart Disease Clinical Trials - Mayo Clinic Research

    ... oral="" dose)="" or="" titrated="" estradiol="" dosing="" to="" achieve="" average="" premenopausal="" estradiol="" level="" (80-120="" pg/ml),="" to ...